Disclosures for "Aggressive Multiple Sclerosis: Clinical Phenotype and Treatment Within a Randomised Clinical Trial of Autologous Haematopoietic Stem Cell Transplantation vs High Efficacy Disease Modifying Treatment"
-
Dr. Brittain has nothing to disclose.
-
-
Ms. Glover has nothing to disclose.
-
Dr. Loban has nothing to disclose.
-
Paolo Muraro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cellerys AG. The institution of Paolo Muraro has received research support from NIHR. The institution of Paolo Muraro has received research support from Benaroya Research Institute. Paolo Muraro has received personal compensation in the range of $10,000-$49,999 for serving as a Expert assistance with Teva. Paolo Muraro has received personal compensation in the range of $10,000-$49,999 for serving as a Expert assistance with Zentiva.
-
Ms. Papaioannou has received publishing royalties from a publication relating to health care.
-
Dr. Roldan Galvan has nothing to disclose.
-
Dr. Sharrack has nothing to disclose.
-